With SpeeDx CT/GC/TV/MGPlex, maximize STI organism detection and couple with AMR assays. Streamline your workflow whilst keeping up with sample throughput with this cost-effective solution.
Maximize organism detection and couple with AMR mutation results
Chlamydia trachomatis (CT), Neisseria gonorrhoeae (GC), Trichomonas vaginalis (TV), and Mycoplasma genitalium (MG) are important sexual health organisms that cause infections and complications for millions of people around the globe every year1. A growing concern is the increased resistance to antibiotics that these organisms can acquire, resulting in reduced treatment options and further spread of infection2. Research focussing on anti-microbial markers aids understanding and helps monitor the prevalence of Antimicrobial Resistant (AMR) organisms.
The CT/GC/TV/MGPlex assay enables detection of these four key STI organisms, and the ability to use the same sample extraction to determine antibiotic resistance utilizing SpeeDx’s flagship Antimicrobial Resistance (AMR) products:
CT/GC/TV/MGPlex is Research Use Only (RUO), not for use in diagnostic procedures.
1. Chesson HW, Mayaud P, Aral SO. Sexually Transmitted Infections: Impact and Cost-Effectiveness of Prevention. In: Holmes KK, Bertozzi S, Bloom BR, et al., editors. Major Infectious Diseases. 3rd edition. Washington (DC): 2017 Nov 3. Chapter 10.2.
2. Growing antibiotic resistance forces updates to recommended treatment for sexually transmitted infections. Geneva, Switzerland; World Health Organization: August 30, 2016
3. Tan LY et al, PLOS ONE. 2017; 12(1): e0170087.
4. Todd M. Pryce, Erin J. Haygarth, Jessica Bordessa and Peter A. Boan. “Evaluation of a PlexZyme-Based PCR Assay and Assessment of COVID-19 Surge Testing Throughput Compared to Cobas SARS-CoV-2.” Pathogens 2021, 10, 1088. https://doi.org/10.3390/pathogens10091088